Provided by Tiger Trade Technology Pte. Ltd.

INDIVIOR PLC

35.83
+0.38001.07%
Post-market: 35.40-0.4300-1.20%18:28 EDT
Volume:4.80M
Turnover:172.05M
Market Cap:4.23B
PE:12.95
High:36.14
Open:35.45
Low:35.21
Close:35.45
52wk High:42.81
52wk Low:22.95
Shares:118.00M
Float Shares:109.00M
Volume Ratio:2.32
T/O Rate:4.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):1.64
ROE:12.20%
ROA:26.40%
PB:-20.33
PE(LYR):21.85

Loading ...

Indivior price target lowered to $43 from $46 at Barclays

TIPRANKS
·
Aug 05

Barclays Reaffirms Their Buy Rating on Indivior (INDV)

TIPRANKS
·
Aug 05

Cumberland Pharmaceuticals Q2 Loss Widens After Apotex Transaction

Reuters
·
Aug 05

Arrowhead Pharmaceuticals Q3 Revenue Jumps on Redemplo Growth

Reuters
·
Aug 05

Indivior price target raised to $53 from $50 at Craig-Hallum

TIPRANKS
·
Aug 04

Indivior Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Switzerland's Crispr Therapeutics Q2 Casgevy Revenue Jumps 151%, Net Loss Narrows on FDA Approval for Expansion

Reuters
·
Aug 04

Crinetics Q2 Revenue Jumps on Palsonify Launch, Withdraws Guidance

Reuters
·
Aug 04

Germany's Fresenius Medical Q2 Revenue Beats; 2026 Outlook Reaffirmed

Reuters
·
Aug 04

U.S. Stocks on the MOVE -Visa, Bowhead Specialty, Micron

Reuters
·
Aug 03

Indivior and Supernus announce tax-free merger of equals

TIPRANKS
·
Aug 03

Supernus, Indivior Merge to Strengthen Neuroscience Drug Portfolio

Reuters
·
Aug 03

TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales

Reuters
·
Aug 03

Indivior Announces Merger Agreement to Acquire Supernus

TIPRANKS
·
Aug 03

Indivior Pharmaceuticals, Supernus Pharmaceuticals to Combine in All-Stock Merger

MT Newswires Live
·
Aug 03

Indivior Pharmaceuticals Inc: Supernus Must Pay Co Termination Fee of $101 Mln if the Merger Agreement is Terminated Under Certain Circumstances

THOMSON REUTERS
·
Aug 03

Indivior Pharmaceuticals Beats Q2 Revenue on Sublocade Growth, Raises FY Guidance

Reuters
·
Aug 03

GUIDANCE: (INDV) Indivior Expects 2026 Net Revenue Range $1.30B - $1.37B, vs. FactSet Est of $1.26B

MT Newswires Live
·
Aug 03

Supernus Q2 FY26 Net Loss Widens to $58.4 Million; Revenue Rises 32% to $219.1 Million

Reuters
·
Aug 03

Indivior Q2 Adj. EPS $1.15 Beats $0.87 Estimate, Sales $343.000M Beat $307.550M Estimate

Benzinga Earnings
·
Aug 03